Library
Careers
News
Contact Us
About Us
Our Mission and Vision
What We Do
Our Track Record
Our Location
Our Certificates
Our History
Our Senior Management
Our Offering
Product and Company Life Cycle
Early Development
Consultancy & Fractional Talent
Starting Material/Cell line
Strain Engineering / Development Services
Cell Line Creation
Master Cell / Microbial Banking
Process & CMC Development
cGMP Process Development
Exosome Nasal Formulation Development
cGMP Manufacturing
Process Transfer
Clinical Trial Material
Drug Product: Aseptic Fill & Finish
Business & Strategic Support
Esco Aster Strategic Capital (Fundraising) As A Service With Accredited Investors
By Modality
Animal Health
Canine CAR-T Cell Therapy
Monoclonal Antibodies for Companion Animals
Animal Health Services
Plasmid DNA Manufacturing Services
Extracellular Vesicles
Cell Therapy
Gene Therapy
Human Vaccines
Viral Vector Production Services
Lipid Nanoparticle Development and Formulation Services
Genetically-modified Cell Therapy
Precision Fermentation
Research Services
Enterprise Solutions
Manufacturing Platforms
Adherent Tide Motion
®
Technology
Astericle
™
: The New EV Miracle
Continuous Fermentation
Continuous Flow Chemistry/ Small Molecules
Esco AsterMavors
®
Our Products
COVID-19
API Process Development
Cosmetics and Cosmeceuticals
Functional Peptides
Specialty Diagnostics
How We Work
Library
Careers
News
Contact Us
One World Biosolutions for One Health
Searching
Featured Content
Our Library
Featured Content
HQ 1
st
Issue: May 2021
HQ 2
nd
Issue August 2021
HQ 3
rd
Issue December 2021
HQ 4
th
Issue March 2022
HQ 5
th
Issue June 2022
Leave a Nest and Esco Aster Launch the "Bio Garage" — A Cross-Border Biotech Collaboration Takes Root at Tokyo's Takanawa Gateway
Esco Aster Taking Flight: Harnessing Relationships and Local Insights to Expand Into Japan